loadpatents
Patent applications and USPTO patent grants for Samuelsson; Bertil.The latest application filed is for "protease inhibitors".
Patent | Date |
---|---|
Protease inhibitors Grant 11,312,693 - Oden , et al. April 26, 2 | 2022-04-26 |
Protease Inhibitors App 20210017140 - ODEN; Lourdes Salvador ;   et al. | 2021-01-21 |
Protease inhibitors Grant 10,723,709 - Oden , et al. | 2020-07-28 |
Protease Inhibitors App 20200010434 - ODEN; Lourdes Salvador ;   et al. | 2020-01-09 |
Protease inhibitors Grant 10,329,266 - Oden , et al. | 2019-06-25 |
HCV NS-3 serine protease inhibitors Grant 10,172,846 - Rosenquist , et al. J | 2019-01-08 |
Protease Inhibitors App 20180327371 - ODEN; Lourdes Salvador ;   et al. | 2018-11-15 |
Protease Inhibitors App 20170334867 - ODEN; Lourdes Salvador ;   et al. | 2017-11-23 |
Hcv Ns-3 Serine Protease Inhibitors App 20170196849 - Rosenquist; Asa ;   et al. | 2017-07-13 |
Protease Inhibitors App 20170166538 - ODEN; Lourdes Salvador ;   et al. | 2017-06-15 |
Protease inhibitors Grant 9,428,517 - Oden , et al. August 30, 2 | 2016-08-30 |
Protease Inhibitors App 20160068539 - ODEN; Lourdes Salvador ;   et al. | 2016-03-10 |
Protease inhibitors Grant 9,200,006 - Oden , et al. December 1, 2 | 2015-12-01 |
Protease Inhibitors App 20140221654 - ODEN; Lourdes Salvador ;   et al. | 2014-08-07 |
Protease inhibitors Grant 8,735,395 - Oden , et al. May 27, 2 | 2014-05-27 |
Hcv Polymerase Inhibitors App 20140066398 - ENEROTH; Anders ;   et al. | 2014-03-06 |
Protease Inhibitors App 20130231349 - ODEN; Lourdes Salvador ;   et al. | 2013-09-05 |
HCV Polymerase Inhibitors App 20130143835 - ENEROTH; Anders ;   et al. | 2013-06-06 |
Protease inhibitors Grant 8,426,421 - Oden , et al. April 23, 2 | 2013-04-23 |
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors Grant 8,338,471 - Wallberg , et al. December 25, 2 | 2012-12-25 |
Protease Inhibitors App 20120289519 - ODEN; Lourdes Salvador ;   et al. | 2012-11-15 |
Protease inhibitors Grant 8,242,119 - Oden , et al. August 14, 2 | 2012-08-14 |
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides As Metalloproteinase Inhibitors App 20120015994 - WALLBERG; Hans ;   et al. | 2012-01-19 |
(2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors Grant 8,022,092 - Wallberg , et al. September 20, 2 | 2011-09-20 |
Protease Inhibitors App 20110039862 - Oden; Lourdes Salvadore ;   et al. | 2011-02-17 |
HIV protease inhibitors Grant 7,807,677 - Ekegren , et al. October 5, 2 | 2010-10-05 |
Hcv Ns-3 Serine Protease Inhibitors App 20100166706 - Rosenquist; Asa ;   et al. | 2010-07-01 |
Macrocyclic inhibitors of hepatitis C virus Grant 7,700,552 - Wahling , et al. April 20, 2 | 2010-04-20 |
Control system, computer program product, device and method Grant 7,669,638 - Kollberg , et al. March 2, 2 | 2010-03-02 |
HCV NS-3 serine protease inhibitors Grant 7,671,032 - Rosenquist , et al. March 2, 2 | 2010-03-02 |
HCV NS-3 Serine Protease Inhibitors App 20100003216 - Rosenquist; Asa ;   et al. | 2010-01-07 |
HCV NS-3 serine protease inhibitors Grant 7,608,590 - Rosenquist , et al. October 27, 2 | 2009-10-27 |
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides As Metalloproteinase Inhibitors App 20090215846 - Wallberg; Hans ;   et al. | 2009-08-27 |
Macrocyclic Inhibitors of Hepatitis C Virus App 20090023758 - Wahling; Horst ;   et al. | 2009-01-22 |
Hiv Protease Inhibitors App 20080249102 - Ekegren; Jenny ;   et al. | 2008-10-09 |
Hcv Ns-3 Serine Protease Inhibitors App 20070203072 - Rosenquist; Asa ;   et al. | 2007-08-30 |
Hcv ns-3 serine protease inhibitors App 20070161574 - Rosenquist; Asa ;   et al. | 2007-07-12 |
Control system, computer program product, device and method App 20060162895 - Kollberg; Sten ;   et al. | 2006-07-27 |
Bispidine compounds useful in the treatment of cardiac arrythmias Grant 6,887,881 - Bjor , et al. May 3, 2 | 2005-05-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.